Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model-Reference-Cited by-同舟云学术

Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model

Published:2010-02 Issue:1-3 Volume:627 Page:16-25
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Grant Stephan,Tran Phong,Zhang Qin,Zou Aihua,Dinh Dac,Jensen Jordan,Zhou Sue,Kang Xiaolin,Zachwieja Joseph,Lippincott John,Liu Kevin,Johnson Sarah Ludlum,Scales Stephanie,Yin Chunfeng,Nukui Seiji,Stoner Chad,Prasanna Ganesh,Lafontaine Jennifer,Wells Peter,Li Hui

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. Inhibition of PKCβ by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients;Aiello;Invest. Ophthalmol. Vis. Sci.,2006

2. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction;Bit;J. Med. Chem.,1993

3. Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1H, 4H, 6H) carbaldehyde derivatives;Botrous,2008

4. 6-Substituted pyrrolo[3, 4-c]pyrazoles: an improved class of CDK2 inhibitors;Brasca;Chem. Med. Chem.,2007

5. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412;Campochiaro;Invest. Ophthalmol. Vis. Sci.,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ring-chain transformation of 4-aroyl-5-phenylamino-2,3-dihydrothiophene-2,3-diones: Facile and efficient synthesis of novel pyrrolo[2,3-c]pyrazol-3(2H)-ones and 1,2-dihydro-5H,6H-pyridazine-5,6-diones;Journal of Sulfur Chemistry;2019-12-15

2. Novel N-pyrimidin-4-yl-3-amino-pyrrolo [3, 4-C] pyrazole derivatives as PKC kinase inhibitors: a patent evaluation of US2015099743 (A1);Expert Opinion on Therapeutic Patents;2015-12-14

3. Double-Edged Swords as Cancer Therapeutics: Novel, Orally Active, Small Molecules Simultaneously Inhibit p53–MDM2 Interaction and the NF-κB Pathway;Journal of Medicinal Chemistry;2014-01-24

4. Adeno-Associated Virus Mediated Delivery of a Non-Membrane Targeted Human Soluble CD59 Attenuates Some Aspects of Diabetic Retinopathy in Mice;PLoS ONE;2013-10-22

5. Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats;Vascular Pharmacology;2012-11